Patent directory · USPTO A61K / A61P
Patents matching “THE UNITED STATES OF AMERICA, as represented by th”
2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7186698
Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
granted -
US 7182944
Methods of increasing distribution of nucleic acids
granted -
US 7179899
Composite antibodies of humanized human subgroup IV light chain capable of binding to TAG-72
granted -
US 7179621
Pigment epithelium-derived factor: sequence of the PEDF gene
granted -
US 7175830
Imaging of drug accumulation as a guide to antitumor therapy
granted -
US 7176244
Use of 2-nitropropanol, 2-nitroethane, and 2-nitroethanol for control of microbial pathogens
granted -
US 7169815
3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same
granted -
US 7163818
Bacteriophage having multiple host range
granted -
US 7163673
Sunscreen reagents from hydroxy-substituted acylglycerides
granted -
US 7163935
Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same
granted -
US 7157495
Hexahydrofuro[2,3-B]furan-3-YL-N-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate as retroviral protease inhibitor
granted -
US 7153947
Ixodes salivary anticomplement protein
granted -
US 7153866
Use of tempol for the treatment of Li-Fraumeni syndrome and ataxia telangiectasia
granted -
US 7153882
Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
granted -
US 7150984
Attenuated human rotavirus vaccine
granted -
US 7148323
Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus
granted -
US 7148036
DNA molecules encoding cartilage-derived morphogenetic proteins
granted -
US 7144918
Biologically active macrolides, compositions, and uses thereof
granted -
US 7144986
Polypeptides comprising IL-6 ligand binding receptor domains
granted -
US 7141234
Imaging of drug accumulation as a guide to antitumor therapy
granted -
US 7141661
Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
granted -
US 7141589
Methods of inhibiting formation of vascular channels and methods of inhibiting proliferation
granted -
US 7135303
Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
granted -
US 7132420
Aspartic protease inhibitors
granted